Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Sep-23
- 20-Jun-24
- 18-Jul-24
- 15-Aug-24
- 12-Sep-24
Select bar for recommendation details.
Recommendations | 12-Sep-24 | |
---|---|---|
Buy | 1 | |
Outperform | 4 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Aurinia Pharmaceuticals Inc have a median target of 10.50, with a high estimate of 13.00 and a low estimate of 6.00. The median estimate represents a 45.83% increase from the last price of 7.20.
High | 80.6% | 13.00 |
Med | 45.8% | 10.50 |
Low | -16.7% | 6.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Oct 31, 2024.
Average growth rate | -20.15% |
Average growth rate | +12.08% |
More ▼
Revenue history & estimates in USD
Average growth rate | +9.84% |
Average growth rate | +3,969.05% |
More ▼